These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15910181)

  • 1. Effects of photodynamic therapy on peripheral nerve: in situ compound-action potentials study in a canine model.
    Dole KC; Chen Q; Hetzel FW; Whalen LR; Blanc D; Huang Z
    Photomed Laser Surg; 2005 Apr; 23(2):172-6. PubMed ID: 15910181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers.
    Chen Q; Huang Z; Luck D; Beckers J; Brun PH; Wilson BC; Scherz A; Salomon Y; Hetzel FW
    Photochem Photobiol; 2002 Oct; 76(4):438-45. PubMed ID: 12405153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues--in vivo study in a canine model.
    Huang Z; Chen Q; Dole KC; Barqawi AB; Chen YK; Blanc D; Wilson BC; Hetzel FW
    Photochem Photobiol Sci; 2007 Dec; 6(12):1318-24. PubMed ID: 18046488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer.
    Huang Z; Chen Q; Luck D; Beckers J; Wilson BC; Trncic N; Larue SM; Blanc D; Hetzel FW
    Lasers Surg Med; 2005 Jun; 36(5):390-7. PubMed ID: 15856509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation.
    Huang Z; Chen Q; Trncic N; LaRue SM; Brun PH; Wilson BC; Shapiro H; Hetzel FW
    Radiat Res; 2004 Jun; 161(6):723-31. PubMed ID: 15161347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the new photosensitizer Tookad (WST09) for photodynamic vessel occlusion of the choroidal tissue in rabbits.
    Framme C; Sachs HG; Flucke B; Theisen-Kunde D; Birngruber R
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5437-46. PubMed ID: 17122134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland.
    Huang Z; Haider MA; Kraft S; Chen Q; Blanc D; Wilson BC; Hetzel FW
    Lasers Surg Med; 2006 Aug; 38(7):672-81. PubMed ID: 16799982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts.
    Koudinova NV; Pinthus JH; Brandis A; Brenner O; Bendel P; Ramon J; Eshhar Z; Scherz A; Salomon Y
    Int J Cancer; 2003 May; 104(6):782-9. PubMed ID: 12640688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of cutaneous photosensitivity of TOOKAD (WST09) in preclinical animal models and in patients.
    Weersink RA; Forbes J; Bisland S; Trachtenberg J; Elhilali M; Brún PH; Wilson BC
    Photochem Photobiol; 2005; 81(1):106-13. PubMed ID: 15382963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental evaluation of possible side effects of intra-operative photodynamic therapy on rabbit blood vessels and nerves.
    Kübler AC; Stenzel W; Rühling M; Meul B; Fischer JH
    Lasers Surg Med; 2003; 33(4):247-55. PubMed ID: 14571449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of motexafin lutetium-mediated intraperitoneal photodynamic therapy in a canine model.
    Griffin GM; Zhu T; Solonenko M; Del Piero F; Kapakin A; Busch TM; Yodh A; Polin G; Bauer T; Fraker D; Hahn SM
    Clin Cancer Res; 2001 Feb; 7(2):374-81. PubMed ID: 11234893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the photosensitizer Tookad for photodynamic therapy on the Syrian golden hamster cheek pouch model: light dose, drug dose and drug-light interval effects.
    Borle F; Radu A; Monnier P; van den Bergh H; Wagnières G
    Photochem Photobiol; 2003 Oct; 78(4):377-83. PubMed ID: 14626666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipophilic photosensitizer administration via the prostate arteries for photodynamic therapy of the canine prostate.
    Xiao Z; Owen RJ; Liu W; Tulip J; Brown K; Woo T; Moore RB
    Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):106-14. PubMed ID: 20510305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy with motexafin lutetium for rectal cancer: a preclinical model in the dog.
    Ross HM; Smelstoys JA; Davis GJ; Kapatkin AS; Del Piero F; Reineke E; Wang H; Zhu TC; Busch TM; Yodh AG; Hahn SM
    J Surg Res; 2006 Oct; 135(2):323-30. PubMed ID: 16650871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker.
    Plaks V; Koudinova N; Nevo U; Pinthus JH; Kanety H; Eshhar Z; Ramon J; Scherz A; Neeman M; Salomon Y
    Neoplasia; 2004; 6(3):224-33. PubMed ID: 15153334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study.
    Radakovic-Fijan S; Blecha-Thalhammer U; Kittler H; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2005 Nov; 53(5):823-7. PubMed ID: 16243131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
    van der Veen N; Hebeda KM; de Bruijn HS; Star WM
    Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC.
    Hornung R; Fehr MK; Monti-Frayne J; Tromberg BJ; Berns MW; Tadir Y
    Br J Cancer; 1999 Oct; 81(4):631-7. PubMed ID: 10574248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfusion, oxygenation status and growth of experimental tumors upon photodynamic therapy with Pd-bacteriopheophorbide.
    Kelleher DK; Thews O; Scherz A; Salomon Y; Vaupel P
    Int J Oncol; 2004 Jun; 24(6):1505-11. PubMed ID: 15138594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy in the canine prostate using motexafin lutetium.
    Hsi RA; Kapatkin A; Strandberg J; Zhu T; Vulcan T; Solonenko M; Rodriguez C; Chang J; Saunders M; Mason N; Hahn S
    Clin Cancer Res; 2001 Mar; 7(3):651-60. PubMed ID: 11297261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.